Nothing Special   »   [go: up one dir, main page]

PT1334720E - Preparações que contêm nateglinida - Google Patents

Preparações que contêm nateglinida Download PDF

Info

Publication number
PT1334720E
PT1334720E PT01976817T PT01976817T PT1334720E PT 1334720 E PT1334720 E PT 1334720E PT 01976817 T PT01976817 T PT 01976817T PT 01976817 T PT01976817 T PT 01976817T PT 1334720 E PT1334720 E PT 1334720E
Authority
PT
Portugal
Prior art keywords
nateglinide
containing preparations
antidiabetic
immediate
amorphous
Prior art date
Application number
PT01976817T
Other languages
English (en)
Inventor
N Ninomiya
Chisato Makino
Akira Yabuki
Original Assignee
Ajinomoto Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Kk filed Critical Ajinomoto Kk
Publication of PT1334720E publication Critical patent/PT1334720E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT01976817T 2000-10-24 2001-10-23 Preparações que contêm nateglinida PT1334720E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000324373 2000-10-24

Publications (1)

Publication Number Publication Date
PT1334720E true PT1334720E (pt) 2008-09-30

Family

ID=18801918

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01976817T PT1334720E (pt) 2000-10-24 2001-10-23 Preparações que contêm nateglinida

Country Status (17)

Country Link
US (2) US7605180B2 (pt)
EP (1) EP1334720B1 (pt)
JP (3) JP4501054B2 (pt)
KR (1) KR100869039B1 (pt)
CN (1) CN100352432C (pt)
AT (1) ATE406885T1 (pt)
AU (1) AU2001295999A1 (pt)
BR (1) BR0114896A (pt)
CA (1) CA2426263C (pt)
DE (1) DE60135674D1 (pt)
DK (1) DK1334720T3 (pt)
ES (1) ES2307653T3 (pt)
MX (1) MXPA03003685A (pt)
PT (1) PT1334720E (pt)
RU (1) RU2271805C2 (pt)
TW (1) TWI283573B (pt)
WO (1) WO2002034254A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ20022294A3 (cs) * 1999-12-28 2002-11-13 Ajinomoto Co., Inc. Antidiabetický preparát k orálnímu uľití
AU2001241168B2 (en) * 2000-03-17 2005-06-16 Ajinomoto Co., Inc. Drugs for complications of diabetes and neuropathy and utilization thereof
JP4114200B2 (ja) * 2000-10-18 2008-07-09 味の素株式会社 ナテグリニド結晶の製造方法
RU2287520C2 (ru) * 2000-10-18 2006-11-20 Адзиномото Ко., Инк. Способ получения ацилфенилаланинов
SI1334721T1 (sl) * 2000-10-24 2009-08-31 Ajinomoto Kk Hidrofilni farmacevtski pripravki, ki vsebujejo nateglinid
RU2275354C2 (ru) * 2000-10-24 2006-04-27 Адзиномото Ко., Инк. Способы получения кристаллов в-типа натеглинида
JP4501054B2 (ja) * 2000-10-24 2010-07-14 味の素株式会社 ナテグリニド含有製剤
JP4833464B2 (ja) * 2001-11-28 2011-12-07 大正製薬株式会社 難溶性薬物含有固形製剤の製造方法
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7420084B2 (en) 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
JP4505859B2 (ja) * 2003-08-08 2010-07-21 味の素株式会社 ナテグリニド含有製剤
WO2005020979A1 (en) * 2003-09-03 2005-03-10 Ranbaxy Laboratories Limited A process for the preparation of pharmaceutical compositions of nateglinide
US20070219250A1 (en) * 2003-11-28 2007-09-20 Romi Singh Pharmaceutical Compositions of Nateglinide
JP5168712B2 (ja) * 2004-04-01 2013-03-27 味の素株式会社 ナテグリニド含有製剤
JP5551852B2 (ja) * 2004-08-10 2014-07-16 味の素株式会社 苦味の低減したナテグリニド含有製剤
EP1891971A4 (en) * 2005-01-31 2010-02-03 Ajinomoto Kk MEDICAL COMPOSITION USING HYPERGLY CRAB MEDICAMENT TO TREAT OR TREAT GLUCOSE-INTOLERANCE, BORDERLINE DIABETES, INSULIN RESISTANCE AND HYPERINSULINEMIA
DE102005047561A1 (de) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
SG179497A1 (en) 2007-03-29 2012-04-27 Daiichi Sankyo Co Ltd Pharmaceutical composition
TR200801178A2 (tr) * 2008-02-22 2009-09-23 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Nateglinid ve surfaktan-ph ayarlayıcı sistemi içeren oral tablet kompozisyonları
CN101590063A (zh) * 2008-05-26 2009-12-02 中国科学院上海生命科学研究院 丹参酮iia在制备治疗肥胖及胰岛素抵抗的药物中的应用
KR101792299B1 (ko) 2010-03-19 2017-10-31 다이이찌 산쿄 가부시키가이샤 항응고제의 용출 개선 방법
KR20130087485A (ko) 2010-06-14 2013-08-06 씨아이피엘에이 엘티디. 나테글리니드의 제조 방법
ES2673182T3 (es) 2011-08-10 2018-06-20 Daiichi Sankyo Company, Limited Composición farmacéutica que contiene un derivado de diamina
CN102813636B (zh) * 2012-08-28 2014-04-16 西南药业股份有限公司 那格列奈片及其制备方法
MX370853B (es) * 2013-07-22 2020-01-08 Sandoz Ag Formulaciones que contienen dapagliflozina amorfa.
WO2016198983A1 (en) 2015-06-09 2016-12-15 Bend Research Inc. Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
JP6647902B2 (ja) * 2015-10-30 2020-02-14 株式会社ファンケル 徐放性顆粒剤
KR20240025990A (ko) * 2022-08-19 2024-02-27 주식회사 스카이테라퓨틱스 무정형 수니티닙, 그 제조방법 및 이를 포함한 의약 조성물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
JPH0249720A (ja) * 1988-05-18 1990-02-20 Mitsubishi Kasei Corp 難溶性薬剤組成物
US5041232A (en) * 1990-03-16 1991-08-20 Lever Brothers Company, Division Of Conopco, Inc. Sulfonimines as bleach catalysts
JPH0415221A (ja) 1990-05-08 1992-01-20 Daicel Chem Ind Ltd ポリカーボネートの製造法
DE10199058I2 (de) * 1991-07-30 2006-04-27 Alcm Co Kristalle von N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanin und Verfahren zu ihrer Herstellung
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
EP1586314B1 (en) * 1996-11-15 2011-03-30 Ajinomoto Co., Inc. Nateglinide tablet composition
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
KR100610403B1 (ko) * 1998-01-20 2006-08-10 어플라이드 애널리티컬 인더스트리즈, 인크. 경구용 액상 또는 반-고체 조성물을 포함하는 약제학적 조성물 및 이의 제조방법
US6559188B1 (en) * 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
CZ20022294A3 (cs) * 1999-12-28 2002-11-13 Ajinomoto Co., Inc. Antidiabetický preparát k orálnímu uľití
AU2001241168B2 (en) * 2000-03-17 2005-06-16 Ajinomoto Co., Inc. Drugs for complications of diabetes and neuropathy and utilization thereof
JP4114200B2 (ja) * 2000-10-18 2008-07-09 味の素株式会社 ナテグリニド結晶の製造方法
RU2287520C2 (ru) * 2000-10-18 2006-11-20 Адзиномото Ко., Инк. Способ получения ацилфенилаланинов
SI1334721T1 (sl) * 2000-10-24 2009-08-31 Ajinomoto Kk Hidrofilni farmacevtski pripravki, ki vsebujejo nateglinid
JP4501054B2 (ja) * 2000-10-24 2010-07-14 味の素株式会社 ナテグリニド含有製剤
RU2275354C2 (ru) * 2000-10-24 2006-04-27 Адзиномото Ко., Инк. Способы получения кристаллов в-типа натеглинида
US6830759B2 (en) * 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
JP4505859B2 (ja) * 2003-08-08 2010-07-21 味の素株式会社 ナテグリニド含有製剤

Also Published As

Publication number Publication date
TWI283573B (en) 2007-07-11
CN1482903A (zh) 2004-03-17
DK1334720T3 (da) 2009-01-19
CA2426263C (en) 2010-05-25
JP2010100654A (ja) 2010-05-06
BR0114896A (pt) 2003-08-12
RU2271805C2 (ru) 2006-03-20
MXPA03003685A (es) 2004-01-26
CN100352432C (zh) 2007-12-05
EP1334720A1 (en) 2003-08-13
JP5610165B2 (ja) 2014-10-22
ES2307653T3 (es) 2008-12-01
US7605180B2 (en) 2009-10-20
US20040014815A1 (en) 2004-01-22
WO2002034254A1 (fr) 2002-05-02
JPWO2002034254A1 (ja) 2004-08-26
KR20030042027A (ko) 2003-05-27
EP1334720B1 (en) 2008-09-03
DE60135674D1 (de) 2008-10-16
JP2013028636A (ja) 2013-02-07
KR100869039B1 (ko) 2008-11-17
JP4501054B2 (ja) 2010-07-14
ATE406885T1 (de) 2008-09-15
AU2001295999A1 (en) 2002-05-06
EP1334720A4 (en) 2004-02-04
CA2426263A1 (en) 2003-04-23
US20090203791A1 (en) 2009-08-13

Similar Documents

Publication Publication Date Title
EP1334720A4 (en) PREPARATIONS CONTAINING NATEGLINID
NZ527032A (en) Isoxazoline derivative and herbicide containing the same as the active ingredient
AU2002305578A1 (en) Applanation tonometer
AU2001279972A1 (en) Pesticidal formulations
AU2001230477A1 (en) Active aid for a handheld camera
AU2001269844A1 (en) Self-standing, hand held implements
AU2001279664A1 (en) Endoparasiticidal agents for voluntary oral ingestion by animals
USD469180S1 (en) Elongated applicator handle having a distributor at both ends
USD462616S1 (en) Bottle
ZA9811715B (en) Aqueous insecticidal pour-on treatment.
AU2002225025A1 (en) Agrochemical formulations
USD456051S1 (en) Exercise device
WO2003024933A1 (fr) Derive d'acide 2-phenyle-3-heteroarylpropionique ou son sel et medicaments le contenant
USD488863S1 (en) Containers for components of medical devices
USD454308S1 (en) Bottle
EP1462112A4 (en) MEANS FOR THE TREATMENT OF EYE ACIDITY AND ASSOCIATED DISEASES
USD451971S1 (en) Exercise device
ZA200304928B (en) Medicament containing a polyamine as an active substance.
USD449424S1 (en) Horseshoe shaped novelty hat
USD457990S1 (en) Animal toy ring
USD460565S1 (en) Truss
USD462783S1 (en) Truss
AU2002210538A1 (en) Aqueous agents containing pesticides
AU2001262282A1 (en) 3-(4,5-dihydroisoxazole-5-yl)benzoylcyclohexenones and the use thereof as herbicides
AU6576400A (en) Inactivated vaccine against feline calicivirus disease